2024-11-14 – Press Releases – www.prnewswire.com
Growth of UK facility will enable clinical-grade manufacturing of drug substances for range of biopharmaceutical products BURLINGTON, Mass., Nov. 15, 2024 /PRNewswire/ — SEKISUI Diagnostics’ microbial CDMO business announces it has completed construction of its £15.7 million ($20.7…